Pharmaceutical Composition Using Aliskiren And Avosentan

  • Published: Jul 3, 2008
  • Earliest Priority: Dec 22 2006
  • Family: 12
  • Cited Works: 3
  • Cited by: 0
  • Cites: 3
  • Additional Info: Cited Works Full text
Abstract

The present invention relates to a pharmaceutical composition and method of achieving a therapeutic effect including, but not limited to, the treatment of hypertension, kidney or heart disease in an animal, preferably a mammal including a human subject, using (i) SPP100/aliskiren or a pharmaceutically acceptable salt thereof in combination with (ii) SPP301/avosentan or a pharmaceutically acceptable salt thereof and (iii) a pharmaceutically acceptable carrier.


Claims
Download PDF
Document Preview
Document History
  • Publication: Jul 3, 2008
  • Application: Dec 21, 2007
    WO EP 2007064404 W
  • Priority: Dec 22, 2006
    EP EP 06127175 A

Sign in to the Lens

Feedback